ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
AgomAb Therapeutics
13.06
-0.8800
-6.31%
盤後：
12.81
-0.2500
-1.91%
19:30 EDT
成交量：
19.67萬
成交額：
263.91萬
市值：
6.43億
市盈率：
-2.89
高：
14.10
開：
14.00
低：
12.96
收：
13.94
52周最高：
17.82
52周最低：
8.75
股本：
4,924.80萬
流通股本：
1,383.60萬
量比：
0.90
換手率：
1.42%
股息：
- -
股息率：
- -
每股收益(TTM):
-4.5143
每股收益(LYR):
-168.1598
淨資產收益率：
-39.22%
總資產收益率：
-20.58%
市淨率：
6.00
市盈率(LYR):
-0.08
資料載入中...
總覽
公司
新聞
公告
Agomab宣佈Marino Garcia與Naimish Patel博士加入董事會
投资观察
·
昨天
Agomab公布Ontunisertib治療纖維狹窄型克羅恩病的新時代2B期研究設計方案
美股速递
·
06/24
Agomab獲美國專利授權 肺靶向吸入式ALK5小分子抑制劑AGMB-447進入特發性肺纖維化治療研發階段
美股速递
·
03/26
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/AGMB/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"AGMB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AGMB\",,,,,undefined,":{"symbol":"AGMB","market":"US","secType":"STK","nameCN":"AgomAb Therapeutics","latestPrice":13.06,"timestamp":1789156800000,"preClose":13.94,"halted":0,"volume":196653,"hourTrading":{"tag":"盘后","latestPrice":12.81,"preClose":13.06,"latestTime":"19:30 EDT","volume":107,"amount":1372.17,"timestamp":1789169407302,"change":-0.25,"changeRate":-0.019142,"amplitude":0.019142},"delay":0,"changeRate":-0.06312769010043034,"floatShares":13836000,"shares":49248000,"eps":-4.51426,"marketStatus":"休市中","change":-0.88,"latestTime":"09-11 16:00:00 EDT","open":14,"high":14.1,"low":12.96,"amount":2639111.381379,"amplitude":0.081779,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.51426,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"listingDate":1770354000000,"exchange":"NASDAQ","adjPreClose":13.94,"preHourTrading":{"tag":"盘前","latestPrice":13.88,"preClose":13.94,"latestTime":"07:57 EDT","volume":3,"amount":41.64,"timestamp":1789127822732,"change":-0.06,"changeRate":-0.004304,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":12.81,"preClose":13.06,"latestTime":"19:30 EDT","volume":107,"amount":1372.17,"timestamp":1789169407302,"change":-0.25,"changeRate":-0.019142,"amplitude":0.019142},"volumeRatio":0.8993156799938643},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AGMB\",,,,,undefined,":{"symbol":"AGMB","floatShares":13836000,"roa":"-20.58%","roe":"-39.22%","lyrEps":-168.159829,"volumeRatio":0.8993156799938643,"shares":49248000,"dividePrice":0,"high":14.1,"amplitude":0.081779,"preClose":13.94,"low":12.96,"week52Low":8.75,"pbRate":"6.00","week52High":17.82,"institutionHeld":0,"latestPrice":13.06,"eps":-4.51426,"divideRate":0,"volume":196653,"delay":0,"ttmEps":-4.51426,"open":14,"prevYearClose":16,"prevWeekClose":15.78,"prevMonthClose":13.17,"prevQuarterClose":12.98,"fiveDayClose":14.83,"twentyDayClose":13.945,"sixtyDayClose":10},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AGMB\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AGMB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AGMB\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.75,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":8,"updateTime":1787716800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AGMB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AGMB","date":"2026-09-11","current":-2.893054,"percent":0.527027,"low":-14.725744,"twenty":-11.959423,"median":-8.973278,"eighty":-7.956453,"high":-6.52172,"avg":-9.611341,"sd":2.194544,"marketCap":686516771},"quantilePoints":[{"date":"2026-02-06","current":-14.293959,"twenty":-14.293959,"median":-14.293959,"eighty":-14.293959,"marketCap":779788464},{"date":"2026-02-13","current":-13.901135,"twenty":-14.202947,"median":-13.85921,"eighty":-13.805127,"marketCap":763217959},{"date":"2026-02-20","current":-13.975141,"twenty":-14.020702,"median":-13.811207,"eighty":-13.436782,"marketCap":760781120},{"date":"2026-02-27","current":-14.297833,"twenty":-14.274685,"median":-13.837477,"eighty":-13.631029,"marketCap":780275831},{"date":"2026-03-06","current":-12.944797,"twenty":-14.315694,"median":-13.869306,"eighty":-13.479283,"marketCap":692549629},{"date":"2026-03-13","current":-12.71107,"twenty":-14.294734,"median":-13.805127,"eighty":-12.961754,"marketCap":677928595},{"date":"2026-03-20","current":-11.600011,"twenty":-14.274685,"median":-13.584093,"eighty":-12.695924,"marketCap":618957093},{"date":"2026-03-27","current":-10.84065,"twenty":-14.216331,"median":-13.160447,"eighty":-12.395453,"marketCap":578505566},{"date":"2026-04-02","current":-10.748527,"twenty":-14.066263,"median":-13.052487,"eighty":-11.414439,"marketCap":574119256},{"date":"2026-04-10","current":-9.193391,"twenty":-13.930737,"median":-12.827934,"eighty":-10.709469,"marketCap":497602513},{"date":"2026-04-17","current":-10.018749,"twenty":-13.86294,"median":-12.650405,"eighty":-9.901184,"marketCap":545851924},{"date":"2026-04-24","current":-9.622204,"twenty":-13.825362,"median":-12.457995,"eighty":-9.650988,"marketCap":521483535},{"date":"2026-05-01","current":-7.206485,"twenty":-13.809991,"median":-11.744798,"eighty":-9.486381,"marketCap":528794052},{"date":"2026-05-08","current":-7.639457,"twenty":-13.779732,"median":-11.111376,"eighty":-9.258769,"marketCap":562411874},{"date":"2026-05-15","current":-7.446972,"twenty":-13.702513,"median":-10.748527,"eighty":-8.300034,"marketCap":543697644},{"date":"2026-05-22","current":-7.434647,"twenty":-13.568448,"median":-10.364346,"eighty":-8.115636,"marketCap":538772846},{"date":"2026-05-29","current":-7.796965,"twenty":-13.4527,"median":-9.998785,"eighty":-7.794875,"marketCap":568321631},{"date":"2026-06-05","current":-8.053102,"twenty":-13.287949,"median":-9.784729,"eighty":-7.758816,"marketCap":585558422},{"date":"2026-06-12","current":-6.750851,"twenty":-13.127527,"median":-9.578953,"eighty":-7.536224,"marketCap":486569993},{"date":"2026-06-18","current":-6.929006,"twenty":-13.073014,"median":-9.501773,"eighty":-7.448225,"marketCap":497404547},{"date":"2026-06-26","current":-9.2886,"twenty":-13.035188,"median":-9.467948,"eighty":-7.458553,"marketCap":661400304},{"date":"2026-07-02","current":-8.166663,"twenty":-12.965993,"median":-9.467948,"eighty":-7.479819,"marketCap":584573463},{"date":"2026-07-10","current":-8.975013,"twenty":-12.944797,"median":-9.309036,"eighty":-7.532768,"marketCap":641701114},{"date":"2026-07-17","current":-8.479177,"twenty":-12.71107,"median":-9.193391,"eighty":-7.541408,"marketCap":606735052},{"date":"2026-07-24","current":-8.981683,"twenty":-12.707304,"median":-9.020605,"eighty":-7.554336,"marketCap":638746235},{"date":"2026-07-31","current":-8.723327,"twenty":-12.661785,"median":-8.978348,"eighty":-7.610114,"marketCap":628157921},{"date":"2026-08-07","current":-9.22434,"twenty":-12.557349,"median":-9.00807,"eighty":-7.636377,"marketCap":664847662},{"date":"2026-08-14","current":-8.931525,"twenty":-12.519309,"median":-9.035172,"eighty":-7.716456,"marketCap":686763011},{"date":"2026-08-21","current":-8.496488,"twenty":-12.423423,"median":-8.981683,"eighty":-7.781927,"marketCap":661400304},{"date":"2026-08-28","current":-8.778373,"twenty":-12.380686,"median":-8.974146,"eighty":-7.796268,"marketCap":681591974},{"date":"2026-09-04","current":-9.428222,"twenty":-12.300242,"median":-8.931525,"eighty":-7.867232,"marketCap":730347469},{"date":"2026-09-11","current":-8.858281,"twenty":-11.959423,"median":-8.973278,"eighty":-7.956453,"marketCap":686516771}],"updateTime":1789255054690},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AGMB\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1188543400","title":"Agomab宣佈Marino Garcia與Naimish Patel博士加入董事會","url":"https://stock-news.laohu8.com/highlight/detail?id=1188543400","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188543400?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 04:06","pubTimestamp":1789157208,"startTime":"0","endTime":"0","summary":"比利时安特卫普，2026年9月11日——专注于纤维炎症性疾病的临床阶段生物制药公司Agomab Therapeutics NV今日宣布，在2026年9月11日召开的特别及非常股东大会中，股东已批准提交审议的全部决议。获批决议包括任命Marino Garcia和Naimish Patel博士为公司非执行董事会成员，以及对首次公开募股前未行使认股权证进行合并及拆股调整的提案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AGMB","IPO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186837702","title":"Agomab公布Ontunisertib治療纖維狹窄型克羅恩病的新時代2B期研究設計方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1186837702","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186837702?lang=zh_tw&edition=fundamental","pubTime":"2026-06-24 04:06","pubTimestamp":1782245174,"startTime":"0","endTime":"0","summary":"AgomAb Therapeutics公司宣布，已为其候选药物Ontunisertib针对纤维狭窄型克罗恩病的治疗，完成了名为“Nov-Era”的2B期临床研究方案设计。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGMB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184179798","title":"Agomab獲美國專利授權 肺靶向吸入式ALK5小分子抑制劑AGMB-447進入特發性肺纖維化治療研發階段","url":"https://stock-news.laohu8.com/highlight/detail?id=1184179798","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184179798?lang=zh_tw&edition=fundamental","pubTime":"2026-03-26 19:00","pubTimestamp":1774522815,"startTime":"0","endTime":"0","summary":"生物制药企业AgomAb Therapeutics宣布，其研发的肺靶向吸入式ALK5小分子抑制剂AGMB-447已获得美国专利授权。该药物目前正针对特发性肺纤维化适应症开展临床前研究，通过精准抑制肺泡区域的TGF-β信号通路，有望为患者提供创新治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGMB","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}]}}